Cheapest Tirzepatide Providers in 2026 — Ranked & Reviewed
Tirzepatide is the most effective GLP-1 weight loss medication, but retail prices can hit $1,000+/month. We ranked every legitimate telehealth provider offering tirzepatide by their lowest published monthly cost for 2026 — so you can find a real, affordable option without falling for hidden-fee pricing.
Lowest verified price: $49/mo345 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
345 cheapest tirzepatide providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
Needle-free and microdosed compounded GLP-1 options with lab-monitored care
From /mo$49CoverageCheck intakeMedicationsSemaglutideTirzepatide - Best Budget
mainstream telehealth GLP-1 access
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide patients who want the option to switch between compounded and brand-name GLP-1 through one provider
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatide$99 first-month entry pricing on compounded GLP-1s
From /mo$99Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatide- Nationwide Coverage
budget-conscious shoppers
From /mo$125Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide budget-conscious shoppers
From /mo$133CoverageCheck intakeMedicationsSemaglutideTirzepatidemainstream telehealth GLP-1 access
From /mo$139Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatidecompounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide
From /mo$149Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick Needle-free and microdosed compounded GLP-1 options with lab-monitored care | $49 | SemaglutideTirzepatide | Check intake | Visit → | |
Best Budget mainstream telehealth GLP-1 access | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
 patients who want the option to switch between compounded and brand-name GLP-1 through one provider | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
 $99 first-month entry pricing on compounded GLP-1s | $99 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → | |
Nationwide Coverage budget-conscious shoppers | $125 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 budget-conscious shoppers | $133 | SemaglutideTirzepatide | Check intake | Visit → | |
 mainstream telehealth GLP-1 access | $139 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide | $149 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Telos Rx
Verified partnerBest for: Needle-free and microdosed compounded GLP-1 options with lab-monitored care
Telos Rx is a compounded telehealth platform (Superior Health Solutions LLC) offering GLP-1 weight loss alongside longevity, recovery, and sexual-health peptides. Its GLP-1 line includes compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide, with provider dose adjustments, lab monitoring, free discreet shipping, FSA/HSA, and cancel-anytime. Headline prices are first-month intro rates (from $49); ongoing cost is higher. Compounded meds are not FDA-approved; pharmacy and states unpublished; no LegitScript shown.
Score Breakdown
Pros
- ✓Multiple GLP-1 modalities: compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide
- ✓Provider-led dose adjustments and lab monitoring as your protocol changes
- ✓Free discreet, temperature-controlled shipping (no Telos branding on the outside)
- ✓FSA/HSA eligible and cancel anytime in one click
- ✓Trustpilot rating of 4.9; full compliance suite published (Privacy, Terms, HIPAA, Shipping & returns)
- ✓Integrated care team spanning weight loss, longevity, recovery, and sexual health (peptide-led)
Cons
- ✗Headline pricing is 'first month low as' intro pricing (semaglutide $49, tirzepatide $99) — ongoing monthly cost is higher and shown during intake
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗Compounding pharmacy partner is not named
- ✗State-availability list is not published
- ✗No LegitScript certification displayed
Found
Verified partnerBest for: mainstream telehealth GLP-1 access
Personalized weight care platform with a self-pay membership model plus medication costs.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
MEDVi
Verified partnerBest for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
MEDVi is a telehealth weight-loss platform offering compounded GLP-1 injections and tablets (semaglutide) as well as brand-name Wegovy and Zepbound through licensed US pharmacies. Medical treatment is delivered by OpenLoop Health clinicians and CareGLP Affiliated P.C.s.
Score Breakdown
Pros
- ✓Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
- ✓Oral tablet and injectable formats
- ✓Named US pharmacy partners (Triad Rx, Precision Medicine, RedRock Pharmacy, Beaker Pharmacy & Compounding)
- ✓Clinical oversight through OpenLoop Health provider network and CareGLP Affiliated P.C.s
- ✓Direct-to-home shipping with 24/7 support
Cons
- ✗Refill price for compounded GLP-1 injection ($299) steps up significantly from $179 first-month offer
- ✗Not available in Mississippi or North Dakota (telehealth regulation constraints)
- ✗Alabama and California patients can only receive injectable formats, not tablets, per state law
- ✗Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a synchronous provider visit before prescribing
- ✗No LegitScript or PCAB certification disclosed on the site
YourEra
Verified partnerBest for: $99 first-month entry pricing on compounded GLP-1s
YourEra is a LegitScript-certified telehealth platform offering compounded semaglutide and tirzepatide injections starting at $99 for the first month, with ongoing pricing set after the medical intake. Care runs entirely online, with doctor visits and prescriptions handled remotely. The site is upfront that these compounded medications are not the brand-name drugs Ozempic, Wegovy, Mounjaro, or Zepbound — a candid bit of transparency for the category.
Score Breakdown
Pros
- ✓$99 first-month entry pricing for compounded GLP-1 — among the cheapest in the market
- ✓LegitScript Certified
- ✓Clearly states it's 100% online doctor visits and prescriptions
- ✓Honest that the compounded medications aren't brand-name Ozempic, Wegovy, Mounjaro, or Zepbound
Cons
- ✗Ongoing maintenance-dose price isn't published — ask before committing
- ✗Legal entity name and state of incorporation aren't disclosed
- ✗Pharmacy partners not named — only "state-licensed pharmacies"
- ✗Per-state availability not listed; verify your state ships before buying
- ✗Initial consultation fee not disclosed
- ✗Lab work and ongoing-care details aren't spelled out
Trimi Health
Verified partnerBest for: budget-conscious shoppers
Telehealth provider offering some of the lowest compounded GLP-1 pricing available.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
How to find the cheapest legitimate tirzepatide
Compounded tirzepatide can be far cheaper than brand-name Zepbound — but the cheapest listing isn't automatically the best. Here's how to compare honestly.
What to look for
- Compare the real monthly total. Sort by the ongoing per-month price including membership, not the intro offer. A '$99 first month' can become $300+ ongoing.
- Longer plans win on price, lose on flexibility. 12-month plans post the lowest per-month numbers but require commitment. Balance the savings against not knowing yet how you'll tolerate the medication.
- Never trade safety for price. A rock-bottom price with no named pharmacy or LegitScript listing isn't a deal — it's an unknown. Keep the trust score in view.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.